SELZENTRY

This brand name is authorized in Mexico, United States

Active ingredients

The drug SELZENTRY contains one active pharmaceutical ingredient (API):

1 Maraviroc UNII MD6P741W8A - MARAVIROC

Maraviroc is a member of a therapeutic class called CCR5 antagonists. Maraviroc selectively binds to the human chemokine receptor CCR5, preventing CCR5-tropic HIV-1 from entering cells. Read about Maraviroc

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SELZENTRY Film-coated tablet / Oral solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AX09	Maraviroc	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 396M2008
Country: US	FDA, National Drug Code	Identifier(s): 49702-223, 49702-224, 49702-233, 49702-235, 49702-237